3083 related articles for article (PubMed ID: 765453)
21. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
Azuma I; Yamamura Y
Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
[No Abstract] [Full Text] [Related]
22. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
Ogura T
Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
[No Abstract] [Full Text] [Related]
23. An insight into cancer immunology and immunotherapy.
Thompson RB
Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
[No Abstract] [Full Text] [Related]
24. [Current status of immunotherapy of malignant tumors].
Flad HD; Betzler M; Herfarth C
Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
[No Abstract] [Full Text] [Related]
25. Immunotherapy of cancer in man.
Carter SK
Am Sci; 1976; 64(4):418-23. PubMed ID: 786091
[No Abstract] [Full Text] [Related]
26. The application of immunotherapy to the treatment of cancer.
Powles RL
Pharmacol Ther; 1979; 4(2):281-306. PubMed ID: 386383
[No Abstract] [Full Text] [Related]
27. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
28. Cancer immunotherapy.
Silverstein MJ; Morton DL
Am J Nurs; 1973 Jul; 73(7):1178-81. PubMed ID: 4488713
[No Abstract] [Full Text] [Related]
29. [Immunotherapy of malignant diseases. A way towards the goal?].
Riethmüller G
MMW Munch Med Wochenschr; 1978 Feb; 120(6):161-2. PubMed ID: 305530
[No Abstract] [Full Text] [Related]
30. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
31. Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy.
Pilch YH; Myers GH; Sparks FC; Golub SH
Curr Probl Surg; 1975 Feb; ():1-61. PubMed ID: 1092529
[No Abstract] [Full Text] [Related]
32. Clinical results with immunochemotherapy in 40 cases of advanced tumour.
Narcisi M
Panminerva Med; 1975; 17(5-6):208-10. PubMed ID: 1161322
[No Abstract] [Full Text] [Related]
33. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy of malignancy in humans. Current status.
Holmes EC; Eilber FR; Morton DL
JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402
[TBL] [Abstract][Full Text] [Related]
35. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
36. [Tuberculosis and neoplasms].
Yamamura Y
Nihon Rinsho; 1975 Apr; 33(4):1632-8. PubMed ID: 1169376
[No Abstract] [Full Text] [Related]
37. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
38. Application of transfer factor to clinical immunotherapy.
Greco RS
Surg Gynecol Obstet; 1976 May; 142(5):765-78. PubMed ID: 772850
[No Abstract] [Full Text] [Related]
39. Cancer topics: immunology and cancer revisited.
O'Brien PH
J S C Med Assoc; 1974 Jul; 70(7):223-6. PubMed ID: 4603086
[No Abstract] [Full Text] [Related]
40. [A review on mechanism of anti-tumor action of BCG (author's transl)].
Tokunaga T
Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
